Osteoporosis

View All

Hormone Replacement Therapy Market Analysis
Hormone Replacement Therapy Market: Unveiling the Growth Opportunities and Key Players Exploring the Domain

Hormone Replacement Therapy (HRT) stands as a big ray of hope for individuals affected by the multifaceted challenges of hormonal imbalances. Defined as the administration of synthetic or natural hormones to supplement or replace the body's own hormonal levels, Hormone Replacement Therapy has emerged as a cornersto...

Find More

Latest MedTech News for Centinel and DyAnsys
FDA Approval to Centinel’s Total Disc Replacement Devices; FDA clears DyAnsys’ Neurostimulator; Orthox to Commence FFLEX Study; Cordis Started Enrolment for RADIANCY Clinical Study; Orthofix & LimaCorporate Announce Partnership; Medtronic to Partner With AWS

Orthox Obtains MHRA Approval to Commence FFLEX Study  On July 14, 2022, Orthodox Ltd, a clinical-stage company created medical implants to treat orthopedic problems including damaged knee articular cartilage. It was founded in 2008 by life scientist, Dr. Nick Skaer, and knee surgeon, Professor Oliver Kessle...

Find More

Novel-Upcoming-Osteoporosis-Drugs-Market
What All You Need to Know About Evolving Osteoporosis Therapeutic Landscape?

Osteoporosis can be characterized by a decrease in the density of bone, resulting in fragile bones which can decrease its strength. Osteoporosis leads to an extent of abnormally porous bones that are observed to be very compressible, just like a sponge. This skeleton disorder cripples the bones and consequently res...

Find More

osteoporosis-symptoms-risk-factors-diagnosis-and-treatment-options
How Is Osteoporosis Impacting The Quality Of Life?

Osteoporosis is a significant health burden worldwide and associated with pain and decreased physical, social, and mental well-being. The affected person experiences prolonged immobilisation and limited daily activities, which deteriorates the quality of life. At the economic level, fractures due to osteoporosis re...

Find More

Leading-Causes-of-Death-Worldwide
What are the Top Five Leading Causes of Deaths in the World?

The global healthcare system over the past few decades has transformed exponentially. Today we are living twice as long as our ancestors have lived before. Infrastructure development, technological advancements (such as accurate diagnosis and lesser medical errors), public-private partnerships in healthcare, availa...

Find More

Osteoporosis Market
Emerging drugs bring a positive shift in Global Osteoporosis Market

Osteoporosis is not RARE. As per the International Osteoporosis Foundation (IOF), Osteoporosis affects an estimated 75 million people in Europe, USA and Japan. Approximately 10 million Americans are living with Osteoporosis and around 44 Million are struggling due to low bone density.  Osteoporosis is k...

Find More

World OSTEOPOROSIS Day
World Osteoporosis Day

World OSTEOPOROSIS day, observed on 20th October every year to raise awareness about diagnosis, treatment, protection and prevention of Osteoporosis. This condition develops when bone density increases, the body reabsorbs more of the bone tissue and produces less amount to replace it. Changes in the lifestyle ...

Find More

Amgen reveals price; Bardy raises $35.5M; Kiadis to Acquire CytoSen; Insitro lands a deal

Amgen reveals the price of EVENITY Amgen has set the price of its newly launched Osteoporosis drug Romosozumab (Evenity). Worth USD 21,900 per annum or USD 1,825 a month, the bone-building drug was approved by the FDA recently for the treatment of Osteoporosis in postmenopausal women and now will be available i...

Find More

Osteoporosis New Drug
New Osteoporosis Drug promises to rebuild Bone

Osteoporosis is a bone disease that makes bones weak and brittle. Osteoporosis, as the word says itself “porous bones”. As we age, bone density decreases and even mild stress or a light fall can cause severe damage. If this happens excessively, the result is Osteoporosis. The older bones keep on degrading, and new ...

Find More

CELIAC DISEASE
Celiac Disease – Intestinal damage of Gluten

Celiac Disease (Gluten-Sensitive Enteropathy) is a chronic, autoimmune, inflammatory disease of the small intestine characterized by damage to the lining of the small intestine and typically leads to dyspepsia, malabsorption and a variety of other symptoms. Individuals with Celiac Disease carry DQ2 or DQ8 MHC class ...

Find More